Hypoxia selection of death-resistant cells

A role for Bcl-XL

Zheng Dong, Jinzhao Wang

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Under hypoxia, some cells are irreversibly injured and die, whereas others can adapt to the stress and survive. The molecular and genetic basis underlying cellular sensitivity to hypoxic injury is unclear. Here we have selected death-resistant cells by repeated episodes of hypoxia. The selected cells are cross-resistant to apoptosis induced by staurosporine, azide, and cisplatin. These cells up-regulate Bcl-XL, an anti-apoptotic protein. Bcl-X L interacts with the pro-apoptotic molecule Bax and abrogates its toxicity in mitochondria, resulting in the preservation of mitochondrial integrity, cytochrome c, and cell viability. Down-regulation of Bcl-X L by antisense oligonucleotides or the newly identified Bcl-X L inhibitor chelerythrine restores cellular sensitivity to injury and death. Thus, Bcl-XL is a key molecule for hypoxia selection of death resistance. These findings may have important implications for the development of solid tumors where hypoxia selects for death-resistant cells that are inert to cancer therapy.

Original languageEnglish (US)
Pages (from-to)9215-9221
Number of pages7
JournalJournal of Biological Chemistry
Volume279
Issue number10
DOIs
StatePublished - Mar 5 2004

Fingerprint

Cell Death
Apoptosis Regulatory Proteins
Mitochondria
Molecules
Staurosporine
Azides
Antisense Oligonucleotides
Cytochromes c
Cisplatin
Toxicity
Tumors
Cells
Wounds and Injuries
Apoptosis
Molecular Biology
Cell Survival
Up-Regulation
Down-Regulation
Hypoxia
Neoplasms

ASJC Scopus subject areas

  • Biochemistry

Cite this

Hypoxia selection of death-resistant cells : A role for Bcl-XL. / Dong, Zheng; Wang, Jinzhao.

In: Journal of Biological Chemistry, Vol. 279, No. 10, 05.03.2004, p. 9215-9221.

Research output: Contribution to journalArticle

@article{71aa9ef776194f36864de9faca5a62d0,
title = "Hypoxia selection of death-resistant cells: A role for Bcl-XL",
abstract = "Under hypoxia, some cells are irreversibly injured and die, whereas others can adapt to the stress and survive. The molecular and genetic basis underlying cellular sensitivity to hypoxic injury is unclear. Here we have selected death-resistant cells by repeated episodes of hypoxia. The selected cells are cross-resistant to apoptosis induced by staurosporine, azide, and cisplatin. These cells up-regulate Bcl-XL, an anti-apoptotic protein. Bcl-X L interacts with the pro-apoptotic molecule Bax and abrogates its toxicity in mitochondria, resulting in the preservation of mitochondrial integrity, cytochrome c, and cell viability. Down-regulation of Bcl-X L by antisense oligonucleotides or the newly identified Bcl-X L inhibitor chelerythrine restores cellular sensitivity to injury and death. Thus, Bcl-XL is a key molecule for hypoxia selection of death resistance. These findings may have important implications for the development of solid tumors where hypoxia selects for death-resistant cells that are inert to cancer therapy.",
author = "Zheng Dong and Jinzhao Wang",
year = "2004",
month = "3",
day = "5",
doi = "10.1074/jbc.M312225200",
language = "English (US)",
volume = "279",
pages = "9215--9221",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "10",

}

TY - JOUR

T1 - Hypoxia selection of death-resistant cells

T2 - A role for Bcl-XL

AU - Dong, Zheng

AU - Wang, Jinzhao

PY - 2004/3/5

Y1 - 2004/3/5

N2 - Under hypoxia, some cells are irreversibly injured and die, whereas others can adapt to the stress and survive. The molecular and genetic basis underlying cellular sensitivity to hypoxic injury is unclear. Here we have selected death-resistant cells by repeated episodes of hypoxia. The selected cells are cross-resistant to apoptosis induced by staurosporine, azide, and cisplatin. These cells up-regulate Bcl-XL, an anti-apoptotic protein. Bcl-X L interacts with the pro-apoptotic molecule Bax and abrogates its toxicity in mitochondria, resulting in the preservation of mitochondrial integrity, cytochrome c, and cell viability. Down-regulation of Bcl-X L by antisense oligonucleotides or the newly identified Bcl-X L inhibitor chelerythrine restores cellular sensitivity to injury and death. Thus, Bcl-XL is a key molecule for hypoxia selection of death resistance. These findings may have important implications for the development of solid tumors where hypoxia selects for death-resistant cells that are inert to cancer therapy.

AB - Under hypoxia, some cells are irreversibly injured and die, whereas others can adapt to the stress and survive. The molecular and genetic basis underlying cellular sensitivity to hypoxic injury is unclear. Here we have selected death-resistant cells by repeated episodes of hypoxia. The selected cells are cross-resistant to apoptosis induced by staurosporine, azide, and cisplatin. These cells up-regulate Bcl-XL, an anti-apoptotic protein. Bcl-X L interacts with the pro-apoptotic molecule Bax and abrogates its toxicity in mitochondria, resulting in the preservation of mitochondrial integrity, cytochrome c, and cell viability. Down-regulation of Bcl-X L by antisense oligonucleotides or the newly identified Bcl-X L inhibitor chelerythrine restores cellular sensitivity to injury and death. Thus, Bcl-XL is a key molecule for hypoxia selection of death resistance. These findings may have important implications for the development of solid tumors where hypoxia selects for death-resistant cells that are inert to cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=1542305379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542305379&partnerID=8YFLogxK

U2 - 10.1074/jbc.M312225200

DO - 10.1074/jbc.M312225200

M3 - Article

VL - 279

SP - 9215

EP - 9221

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 10

ER -